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Streszczenie
Cel: Celem pracy była retrospektywna ocena częstości wystę-
powania powikłań oraz wpływu czasu pooperacyjnego na ich 
występowanie u dorosłych chorych po operacji Fontana w od-
ległym okresie obserwacji.
Materiał i metody: Do badania włączono kolejnych 48 chorych 
po operacji Fontana (26 M, 22 K) w wieku od 18 do 40 lat, śred-
nio 23 ±5 lat. U wszystkich chorych wykonano badanie klinicz-
ne, echokardiograficzne, laboratoryjne, EKG, wysiłkowy test 
spiroergometryczny oraz oceniono saturację krwi tętniczej. 
W zależności od czasu, który minął od operacji, chorzy zostali 
podzieleni na trzy grupy: do 15 lat, 16–20 lat i powyżej 20 lat.
Wyniki: Powikłania zakrzepowo-zatorowe występowały u 10 
chorych (21%). Nadkomorowe zaburzenia rytmu zarejestrowano 
u 10% chorych, podczas gdy komorowe zaburzenia rytmu u 4%. 
Saturacja krwi tętniczej w badanej grupie wynosiła 89%, sini-
ce stwierdzono u 25% chorych. Objawy enteropatii wysiękowej 
występowały u 4% badanych. Analizując wartości parametrów 
u pacjentów w zależności od czasu pooperacyjnego, stwierdzo-
no wysoce istotne różnice w VO2peak, VO2%N, saturacji krwi 
tętniczej i w wartości hematokrytu dla wszystkich grup. Wraz 
z upływem czasu od operacji obserwowano upośledzenie funkcji 
skurczowej komory systemowej (χ2 p = 0,001; Fisher p = 0,001) 
oraz zwiększanie się stopnia niedomykalności zastawki przed-
sionkowo-komorowej (χ2 p < 0,001; Fisher p < 0,001).
Wnioski: U dorosłych chorych po operacji Fontana z czasem 
obserwuje się upośledzenie funkcji skurczowej pojedynczej 
komory, zwiększenie stopnia niedomykalności zastawki przed-
sionkowo-komorowej oraz obniżenie tolerancji wysiłku. Nasila 
się sinica oraz zwiększa poziom hematokrytu. Chorzy ci wy-
magają systematycznej oceny w specjalistycznych centrach 
zajmujących się leczeniem dorosłych z wrodzonymi wadami 
serca w celu wczesnego rozpoznania i odpowiedniego leczenia 
w przypadku stwierdzonych powikłań. 
Słowa kluczowe: operacja Fontana, powikłania odległe.
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Abstract
Aim of the study: The aim of the retrospective study was to 
determine the prevalence of late complications in adult pa-
tients after the Fontan operation (FO). 
Material and methods: Forty-eight Caucasians patients after 
staged FO (26 men, 22 women) aged between 18 and 40 years 
(mean 23 ±5 uears) were included in the study. The evalua-
tion included echocardiograms, electrocardiograms, cardiopul-
monary exercise tests (CPX), oxygen saturation and medical 
history and laboratory tests. Based on the postoperative time, 
the patients were divided into three groups: up to 15 years, 
between 16 and 20 years and above 20 years after surgery.
Results: Thromboembolism was present in 10 patients (21%). 
Supraventricular tachycardias were noted in 10% of subjects, 
ventricular tachycardia in 4% of patients. Mean oxygen satura-
tion was 89%, cyanosis was seen in 25% of patients. Protein-
losing enteropathy appeared in 4%. While analyzing param-
eter values in patients belonging to various postoperative time 
groups, highly significant differences were noted in VO2peak, 
VO2%N, SaO2 (oxygen saturation), and HCT. Along with an 
increased postoperative period, the SV function deteriorated 
(χ2 p = 0.001, Fisher p = 0.001) and a higher degree of systemic 
atrioventricular valve regurgitation was detected (χ2 p < 0.001, 
Fisher p < 0.001).
Conclusions: In adults after the Fontan operation, the systolic 
function of a single ventricle deteriorates with time, atrioven-
tricular valve regurgitation increases and exercise tolerance is 
reduced. Cyanosis is increased and hematocrit levels are el-
evated. Such patients require regular assessment in specialist 
centers for adult patients with congenital heart defects.
Key words: Fontan operation, long-term follow-up.
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Introduction
Recent progress in cardiac surgery and pediatric cardi-
ology has resulted in large numbers of adult patients who 
have surgically corrected complex congenital heart defects. 
The Fontan operation (FO) has become the treatment of 
choice in patients with a univentricular heart (single ven-
tricle – SV); the anomaly accounts for about 8% of all con-
genital heart defects. The lack of a chamber that pumps 
blood to the pulmonary vascular bed results in restricted 
pulmonary venous return, which in turn decreases preload 
in the SV. In the Fontan-type circulation, cardiac output is 
approximately 70% lower as compared to the biventricular 
heart [1]. The most significant factor affecting the cardiac 
output is believed to be systemic ventricle preload, which 
depends on the volume of blood flowing through the heart 
and the presence of fenestrations. Blood flow through 
the pulmonary vascular bed depends on pulmonary resist-
ance and a pressure gradient between the central venous 
pressure and left atrial pressure; after the classic FO, it also 
depends on right atrial contraction [1, 2]. Despite the im-
provements in surgical techniques that reduce periopera-
tive mortality, late deterioration in functional status can be 
observed with longer duration of follow-up [3]. Khairy et al. 
[4] described a 20-year survival rate of 83%, and found no 
differences among patients operated on by various meth-
ods. Masamichi et al. [3] reported a 20-year survival rate of 
87%; in their study patients with fenestrated total cavopul-
monary connection (TCPC) had better cardiac output and 
lower incidence of arrhythmias. 
Previous studies demonstrated evidence of numerous 
complications such as increase of pulmonary resistance, 
arrhythmia, thromboembolic complications, cyanosis and 
heart failure after FO [2, 3, 5, 6]. 
The aim of this retrospective study was to determine 
the prevalence of late complications in adult patients late 
after the Fontan operation. 
Material and methods
Forty-eight Caucasian Fontan patients (26 men, 22 wom-
en) aged between 18 and 40 years (mean 23 ±5 years) were 
included in the study, as previously described in detail [7]. This 
was a multicenter study. Clinical, demographic and anatomi-
cal features, previous interventions and complications were 
studied by a retrospective analysis of all the clinical records. 
The patients underwent clinical assessment including physi-
cal examination, functional status (NYHA class), the pres-
ence of arrhythmias and medical therapy. Oxygen saturation 
(SaO2) was measured by pulse oximetry in the room air.
Echocardiograms were interpreted by two readers and 
included the assessment of SV morphology and function 
and atrioventricular and semilunar valve function. The SV 
function was assessed semi-quantitatively using the fol-
lowing scale: 1, good; 2, fair; 3, decreased, and 4, poor [8]. 
Semi-quantitative assessment was also employed in evalu-
ating valvular competence, the scale being 0, none; 1, triv-
ial; 2, moderate; 3, severe [9]. The diagnosis of deep-vein 
thrombosis was established by a positive finding of color 
duplex sonography (visualization of an intraluminal throm-
bus in the calf, popliteal, femoral, or iliac veins). The diag-
nosis of pulmonary embolism was based on the presence 
of typical symptoms and positive results of high-resolution 
spiral computed tomography. In Fontan patients with previ-
ous thromboembolic events, thrombophilia screening was 
performed [10]. The cardiopulmonary exercise test (CPX) 
was performed to evaluate exercise tolerance. The peak 
oxygen uptake was determined at peak exercise as VO2peak 
(ml/kg/min) and as a percentage of a normal value calcu-
lated for the age and sex (VO2%N). Fasting blood samples 
were collected from the antecubital vein on the same day 
that clinical data were recorded. Red blood cells (RBC), 
platelet count, hematocrit (HCT), hemoglobin (HGB), total 
protein, alanine aminotransferase (ALT), creatinine, C-reac-
tive protein (CRP) and international normalized ratio (INR) 
were assayed by routine laboratory techniques.
Based on the postoperative time, the patients were di-
vided into three groups: up to 15 years, between 16 and 20 
years, and above 20 years after surgery.
The University Ethical Committee approved the study 
and patients provided written informed consent. 
Statistical analysis 
Descriptive statistics was employed to describe 
the data. The associations between the groups with vari-
ous post-operative durations and qualitative changes were 
analyzed using two-way tables, the χ2 test and the Fisher 
exact test; additionally, the χ2 test for a trend was em-
ployed. 
In the case of quantitative scales, their conformity to 
a theoretical normal distribution was analyzed by the Sha-
piro-Wilk test and the uniformity of variances in groups 
with various post-operative times was analyzed using 
the Brown-Forsythe test.
The analyses that compared the results of the investi-
gated quantitative scales depending on post-operative time 
were performed using the analysis of variance (ANOVA) 
with the Kruskal-Wallis test with the Dunn post hoc test. 
Test probability of p < 0.05 was deemed significant, 
while the value of p < 0.01 was deemed highly significant. 
The analysis of the results was performed using the PQStat 
ver. 1.4.2.324 package and the R software.
Results
The patient group consisted of 20 (42%) patients with 
tricuspid atresia, 9 (19%) patients with ventricular septal 
defect and pulmonary atresia, 9 (19%) patients with dou-
ble outlet right ventricle with left ventricular hypoplasia, 
and 10 subjects (21%) with right ventricular hypoplasia. 
Of this number, 17 (35%) patients underwent direct right 
atrium-pulmonary artery connection (APC), 2 (4%) under-
went modified Fontan surgery, and the remaining 29 (60%) 
patients underwent TCPC. 
The mean age at surgery was 5 ±9.8 (1-17) years. 
The mean postoperative time was 18 (3-30) years. Ten pa-
tients were treated with warfarin (21%), 16 with acetylsali-
359
CARDIAC SURGERY
Kardiochirurgia i Torakochirurgia Polska 2013; 10 (4)
cylic acid (33%), 2 took enoxaparin (4%), 3 prednisone (6%), 
17 spironolactone (35%), 4 furosemide (8%), 2 sotalol (4%) 
and 1 sildenafil (2%). 
At the last follow-up, the NYHA class was assessed as I in 
14 (29%) patients, II in 32 (67%) and III in 2 subjects (4%). There 
were no significant associations between postoperative time 
and NYHA class (χ2 p = 0.3, Fisher p = 0.4).
Upon analyzing parameter values in patients belong-
ing to various postoperative time groups, highly signifi-
cant differences were noted both in VO2peak and in VO2%N 
(p < 0.01) in all the groups. Along with increasing post-
operative time, VO2 and VO2%N steadily decreased. In 
the case of HCT, significant differences were observed only 
for the groups up to 15 years and 16-20 years after surgery 
(42 ±8.4 vs. 48.8 ±8.3; p < 0.05). There were no inter-group 
differences in RBC, HGB, platelet count, ALT, creatinine, INR 
and total protein (Table I).
Cardiac rhythm
Predominant sinus rhythm was present in 42 (88%) 
patients. Supraventricular tachyarrhythmias were noted 
in 5 (10%) patients; in this number, chronic atrial fibrilla-
tion was recorded in 4 (8%) and supraventricular tachy-
cardia in 1 (2%) patient. One patient (2%) underwent 
a pacemaker implant and had a paced rhythm. In 2 (4%) 
patients, complex ventricular arrhythmias in the form of 
non-sustained ventricular tachycardia were recorded. All 
the 4 (8%) patients presenting with arrhythmia leading 
to cardiac insufficiency were referred for radiofrequency 
(RF) ablation procedures. There were no significant differ-
ences in the frequency of arrhythmia paroxysms between 
the groups (χ2 p = 0.8, Fisher p = 0.8). 
Echocardiography
The morphology of SV was left in 39 (81%) and right in 
9 (19%) subjects. The SV function was assessed as good in 
25 (52%), fair in 16 (33%), decreased in 5 (10%) and poor 
in 2 (4%) patients. There were significant associations be-
tween postoperative time and SV function (χ2 p = 0.001, 
Fisher p = 0.001). Along with an increased postoperative 
period, the SV function deteriorated (Fig. 1). We did not find 
a correlation between SV morphology and SV function and 
degree of systemic atrioventricular valve regurgitation. 
Significant atrioventricular valve regurgitation was pre-
sent in 2 (4%) patients, moderate in 8 (17%) and mild in 
10 (21%) subjects. A highly significant association was also 
demonstrated between the degree of systemic atrioventric-
ular valve regurgitation and postoperative period duration 
(χ2 p < 0.001, Fisher p < 0.001) – Fig. 2. Moderate aortic valve 
regurgitation was observed in 5 (10%) patients and mild 
in 9 (19%) patients. No significant associations (χ2 p = 0.2, 
Fisher p = 0.3) were noted between postoperative time and 
prevalence of aortic valve regurgitation. The associations 
did not reach statistical significance (p = 0.6).
Thromboembolism
Thromboembolic complications were noted in 10 (21%) 
patients. Three patients presented with a thrombus in 
a lateral tunnel, 1 patient had a history of ischemic cerebral 
stroke, and 6 were diagnosed with chronic venous throm-
bosis. All the patients with thromboembolic complications 
were treated with oral anticoagulants.
No significant association (χ2 p = 0.2, Fisher p = 0.2) was 
observed between postoperative duration and prevalence 
of thromboembolic complications. The relation was not 
statistically significant (p = 0.09), although the percentage 
of patients presenting with complications increased with 
increasing postoperative time (Fig. 3). 
Symptoms of exudative enteropathy manifesting as low 
protein levels, ascites and lower extremity edema were ob-
served only in 2 patients (4%) in the group above 20 years 
after surgery. No significant association (χ2 p = 0.1, Fisher 
p = 0.2) was noted between postoperative duration and 
prevalence of exudative enteropathy symptoms. 
SV function – 1 SV function – 2 SV function – 3 SV function – 4 
SV – single ventricle
Fig. 1. SV function in patient groups depending on postoperative time
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Fig. 2. Atrio-ventricular valve regurgitation in patient groups de-
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complications no complications
Cyanosis
The mean arterial oxygen saturation was 89 ±7%. Sig-
nificant differences were observed in SaO2 between groups 
with various postoperative durations (92.1 ±6 vs. 88.5 ±3.3 
vs. 84.9 ±8.7; p < 0.05) (Table I, Fig. 4). Cyanosis was noted 
in 12 (25%) patients. No significant association (χ2 p = 0.1, 
Fisher p = 0.09) was seen between postoperative duration 
and prevalence of cyanosis. However, the trend was sig-
nificant (p = 0.03); in other words, along with an increas-
ing follow-up time, the number of cyanosis cases steadily 
increased (Fig. 5).
Discussion
Single ventricle patients after the Fontan operation are 
a heterogeneous group with respect to underlying etiol-
ogy, method of correction and clinical status. We presented 
a retrospective analysis of the prevalence of late complica-
tions in adult Fontan patients who were admitted to spe-
cialized centers for adult congenital heart diseases. 
In the present study, the most frequent long-term com-
plication in adult patients after the Fontan procedure was 
cyanosis, which occurred in 25% of the patients. Saturation 
of arterial blood with oxygen was 89% on average. There 
was a significant decrease in SatO2 with increasing time 
elapsed from the operation. Moreover, there was also an 
increased incidence of cyanosis, significant deterioration of 
ventricular systolic function, an increased degree of atrio-
ventricular valve regurgitation, and increased RBC and HCT 
with increasing postoperative time. Some other authors 
have reported similar findings [11, 12]. Cyanosis might be 
a result of abnormal communications between the arter-
ies and veins of the lung, polyglobulia, intrahepatic venous 
communications and intracardiac shunts, for instance fen-
estrations [2]. Furthermore, impaired ventricular systolic 
function and atrioventricular valve regurgitation leading to 
increased ventricular end-systolic pressure increase venous 
congestion, and formation of abnormal communications in 
the lung and in the liver, which in turn increases cyanosis 
[5, 8]. Giardini et al. [13] demonstrated that oral administra-
tion of sildenafil in Fontan patients was associated with 
a decrease in pulmonary resistance, an increase in cardiac 
index and exercise tolerance improvement. In our study, 
sildenafil was initiated in 2% of patients, in whom clinical 
improvement was achieved.
In the present study, thromboembolic complications 
occurred in 21% of patients. There was no significant re-
lationship between postoperative time and the incidence 
of thromboembolic complications, although the rate of 
postoperative complications increased with time elapsed 
from the procedure. In previous investigations, thrombo-
embolic complications have been detected in 3% to 33% of 
patients, depending on follow-up, study protocol and diag-
nostic evaluation. Varma et al. [14] used CT and ventilation/
perfusion lung scintigraphy and detected old asymptomatic 
pulmonary embolisms in 17% of patients. A pulmonary em-
bolism impairs blood flow in the lung and may aggravate 
cyanosis. Balling et al. [15] found asymptomatic thrombi in 
Fig. 3. Prevalence of thromboembolic complications in patient gro-
ups depending on postoperative time 
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Fig. 5. SaO2 in patient groups depending on postoperative time 
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Fig. 4. Incidence of cyanosis in patient groups depending on po-
stoperative time
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Tab. I. Values of the investigated parameters depending on follow-up duration 
Follow-up 
(group)
Descriptive statistics 
ANOVA
Kruskal-
Wallis test
Dunn 
testMean 
Standard 
deviation 
Minimum Median Maximum 
VO2 ml/kg/min
total 20.44 4.86 14.00 19.50 29.00
1-15 24.15 4.26 14.00 25.50 29.00
< 0.001 < 0.001
a
16-20 19.55 3.72 14.00 19.00 27.00 ab
> 20 16.25 1.90 14.00 16.00 20.00 b
VO2%N
total 49.35 8.27 35.00 48.00 73.00
1-15 55.35 7.70 43.00 55.50 73.00
< 0.001 < 0.001
a
16-20 47.46 5.11 40.00 46.00 55.00 b
> 20 43.00 5.37 35.00 40.00 54.00 b
RBC
total 5.43 0.90 3.66 5.30 9.93
1-15 5.39 1.20 3.66 5.30 9.93
0.9 0.516-20 5.55 0.74 4.29 5.75 6.67
> 20 5.39 0.54 4.58 5.30 6.41
HGB
total 15.76 1.66 12.10 15.70 18.90
1-15 15.34 1.81 12.10 15.40 18.10
0.2 0.216-20 16.44 1.48 13.30 16.40 18.20
> 20 15.75 1.50 13.70 15.60 18.90
HCT
total 45.14 6.96 25.17 46.50 55.30
1-15 42.00 8.42 25.17 44.70 51.90
0.02 0.03
a
16-20 48.75 4.34 39.30 49.80 54.30 b
> 20 46.19 4.78 33.80 46.00 55.30 ab
PLT
total 148.77 47.85 64.00 143.00 307.00
1-15 161.55 56.91 64.00 156.00 307.00
0.3 0.316-20 139.08 35.05 101.00 142.00 234.00
> 20 140.13 42.86 67.00 136.00 232.00
ALT
total 29.40 11.77 4.00 29.00 60.00
1-15 31.54 10.50 16.00 29.00 60.00
0.3 0.416-20 25.08 11.67 4.00 21.00 45.00
> 20 30.29 13.20 7.00 32.00 58.00
total protein 
total 72.97 10.37 36.20 75.00 89.00
1-15 74.83 6.16 64.00 76.50 89.00
0.2 0.116-20 74.39 11.82 36.20 77.30 82.90
> 20 69.25 12.95 39.40 70.80 88.00
creatinine
total 74.01 15.36 23.00 75.50 102.00
1-15 75.20 12.16 50.20 75.50 101.00
0.4 0.316-20 68.82 16.80 31.00 68.00 91.00
> 20 76.91 17.70 23.00 78.00 102.00
PT INR
total 1.16 0.19 0.60 1.12 1.90
1-15 1.13 0.15 0.60 1.12 1.37
0.6 0.916-20 1.16 0.23 0.80 1.12 1.60
> 20 1.20 0.23 1.00 1.12 1.90
SaO2 (%)
total 88.98 6.99 70.00 92.00 97.00
1-15 92.15 5.99 70.00 93.00 97.00
0.02 0.03
a
16-20 88.54 3.36 84.00 89.00 94.00 ab
> 20 84.86 8.72 70.00 87.00 96.00 b
ALT – alanine aminotransferase; HCT – hematocrit; HGB – hemoglobin; INR – international normalized ratio; PLT – platelets; RBC – red blood cell; SaO2 – oxygen 
saturation 
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the Fontan circulation in 33% of patients. The present study 
comprised adult patients >18 years of age with a mean 
follow-up of 18 years. We assessed only the incidence of 
symptomatic thromboembolic complications. The known 
risk factors for the development of thromboembolic com-
plications include arrhythmias, slow venous blood flow, 
cyanosis, liver injury and exudative enteropathy leading to 
loss of proteins involved in blood clotting [16-19]. Previous 
studies showed that adult Fontan patients were character-
ized by enhanced platelet activation and endothelial injury, 
heightened thrombin formation and impaired fibrinolysis. 
Patients after thromboembolic events observed late after 
Fontan surgery display reduced free protein S, increased 
platelet activation and endothelial damage [7]. There are 
no clear anticoagulation treatment guidelines for such 
patients, either. In our group, 33% of participants were on 
antiplatelet therapy and 21% on anticoagulation therapy, 
which concurs with results published by others [6, 12]. 
In the present study, 10% of patients developed su-
praventricular tachyarrhythmias and 4% of patients had 
complex ventricular arrhythmias with non-sustained ven-
tricular tachycardia. Data regarding the actual incidence of 
arrhythmias in adults after the Fontan procedure are scarce. 
In a group of 520 patients, Stephenson et al. [20] found 
supraventricular tachyarrhythmias in 9.4% and ventricular 
tachycardia in 3.5% of patients at 8.6 years after the Fon-
tan procedure. Idorn et al. [21] reported the occurrence of 
heart rhythm disorders in 32% of Danish patients undergo-
ing the Fontan operation at the age > 20 years. Scarring af-
ter atrial incision, site of synthetic fabric sewing and atrial 
remodeling predispose to intra-atrial reentrant tachycardia 
(IART) and atypical atrial flutter. Supraventricular arrhyth-
mia is more frequent in patients with right atrial-pulmo-
nary artery anastomosis [22, 23]. In the present study, 60% 
of the subjects had TCPC; of this number, 23% had patent 
fenestrations. Supraventricular tachycardia may aggravate 
hemodynamics in the Fontan circulation and lead to heart 
failure over a short period of time. RF ablation is performed 
in drug-refractory disorders. In our study, 8% of patients 
had rhythm disorders causing cardiac decompensation. 
RF ablation was successfully performed in 2 cases (50%). 
Other investigators report the efficacy of ablation in 50-70% 
of cases, although recurrent arrhythmia is common [24]. In 
patients with atrial-pulmonary artery anastomosis and re-
fractory arrhythmia, conversion to TCPC with surgical abla-
tion (MAZE) and epicardial lead placement are recommend-
ed. Hiramatsu et al. [25] demonstrated one- and five-year 
survival of 80% and 64%, respectively, after conversion. In 
the present study, the patients did not require reoperation. 
None of the patients was referred for heart transplantation.
Symptoms of exudative enteropathy including low pro-
tein level, low extremity edema and ascites were found in 
4% of patients. Feldt et al. [26] reported that protein los-
ing enteropathy occurred in up to 10% of Fontan patients. 
However, none of these patients had a fenestration. In 
the present group, fenestrations were detected in 23% of 
patients. 
In the present study, the patients who have undergone 
the Fontan operation have a decreased exercise capacity 
with low peak oxygen consumption. Along with increasing 
post-operative time, peak oxygen consumption steadily 
decreased. Diller et al. [27] also found decreased physical 
activity in a group of 321 adult patients after the Fontan 
procedure. The spiroergometric exercise test has no prog-
nostic value in this group of patients. Decreased peak 
oxygen consumption in patients who have undergone 
the Fontan operation is caused by decreased pulmonary 
blood flow, increased dead space, altered chemoreceptor 
function, and impaired systolic function of the single ven-
tricle. In patients with fenestrations, a right-to-left shunt is 
present, which is increased during exercise [27, 28]. Idorn et 
al. [29] demonstrated that the pulmonary diffusing capac-
ity was reduced in Fontan patients because of a reduced 
pulmonary capillary blood volume, whereas the alveolar 
capillary membrane diffusing capacity was preserved. 
However, spiroergometric exercise tests play a significant 
role in long-term follow-up of patients with single ventri-
cles. Objective assessment of exercise capacity facilitates 
prescription of physical activity and is useful in the selec-
tion process for invasive treatment.
Pregnancy carries high risks in women after FO. In our 
presented group there were 22 (46%) women, of whom 3 
(14%) were pregnant. Three deliveries were terminated by 
cesarean section, while the other 3 ended with miscarriage. 
In Fontan patients pregnancy should be actively discour-
aged. Pregnant women after FO should be referred to spe-
cialist centers and require multidisciplinary care [30]. 
Several limitations of the study should be acknowl-
edged. First, it was a retrospective study.
Second, the number of patients in the study was small 
and heterogeneous with respect to cardiac diagnosis and 
Fontan surgery type. The true incidence of thrombosis 
may have been underestimated because we analyzed only 
symptomatic events and imaging studies were not per-
formed in all the patients. Furthermore, we did not perform 
hemodynamic measurements and determine single ven-
tricular function on magnetic resonance. However, Margos-
sian et al. [31] reported similar interobserver reproducibility 
for echocardiographic and CMR assessment of SV systolic 
function. Overall, the CMR data were inadequate or incom-
plete in 30% of patients in whom the test was performed, 
predominantly due to metallic artifacts [32].
Conclusions
In adults after the Fontan operation, the systolic func-
tion of a single ventricle deteriorates with time, atrioven-
tricular valve regurgitation increases and exercise tolerance 
is reduced. Cyanosis is increased and hematocrit levels are 
elevated. Fontan patients require regular assessment in 
specialist centers for adult patients with congenital heart 
defects.
The study was funded by Jagiellonian University Medical 
College.
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